Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1977 1
1979 1
1980 1
1981 1
1982 2
1983 3
1984 1
1985 2
1986 4
1987 2
1988 4
1989 5
1991 5
1992 13
1993 13
1994 12
1995 5
1996 11
1997 12
1998 16
1999 14
2000 22
2001 14
2002 24
2003 23
2004 25
2005 42
2006 30
2007 52
2008 57
2009 63
2010 58
2011 66
2012 69
2013 67
2014 83
2015 86
2016 106
2017 104
2018 99
2019 113
2020 111
2021 99
2022 96
2023 75
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

1,498 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Post-treatment Disease Complication"
Page 1
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Garcia-Olmo D, Gilaberte I, Binek M, D Hoore AJL, Lindner D, Selvaggi F, Spinelli A, Panés J. Garcia-Olmo D, et al. Dis Colon Rectum. 2022 May 1;65(5):713-720. doi: 10.1097/DCR.0000000000002325. Dis Colon Rectum. 2022. PMID: 34890373 Free PMC article. Clinical Trial.
OBJECTIVE: The goal of this study was to assess the long-term safety and efficacy of darvadstrocel at 2 years post-treatment in patients with Crohn's disease and complex perianal fistulas. DESIGN: This was a phase 3 double-blind randomized controlled s …
OBJECTIVE: The goal of this study was to assess the long-term safety and efficacy of darvadstrocel at 2 years post-treatment i …
On the causes of persistent apical periodontitis: a review.
Nair PN. Nair PN. Int Endod J. 2006 Apr;39(4):249-81. doi: 10.1111/j.1365-2591.2006.01099.x. Int Endod J. 2006. PMID: 16584489 Review.
Further, there are extraradicular factors -- located within the inflamed periapical tissue -- that can interfere with post-treatment healing of apical periodontitis. The causes of apical periodontitis persisting after root canal treatment have not been well characte …
Further, there are extraradicular factors -- located within the inflamed periapical tissue -- that can interfere with post-treatme
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators. Yokoyama M, et al. Lancet. 2007 Mar 31;369(9567):1090-8. doi: 10.1016/S0140-6736(07)60527-3. Lancet. 2007. PMID: 17398308 Clinical Trial.
BACKGROUND: Epidemiological and clinical evidence suggests that an increased intake of long-chain n-3 fatty acids protects against mortality from coronary artery disease. ...FINDINGS: At mean follow-up of 4.6 years, we detected the primary endpoint in 262 (2.8%) pat …
BACKGROUND: Epidemiological and clinical evidence suggests that an increased intake of long-chain n-3 fatty acids protects against mo …
Cognitive training for people with mild to moderate dementia.
Bahar-Fuchs A, Martyr A, Goh AM, Sabates J, Clare L. Bahar-Fuchs A, et al. Cochrane Database Syst Rev. 2019 Mar 25;3(3):CD013069. doi: 10.1002/14651858.CD013069.pub2. Cochrane Database Syst Rev. 2019. PMID: 30909318 Free PMC article.
SEARCH METHODS: We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialised Register, on 5 July 2018. ALOIS contains records of clinical trials identified through monthly searches of several major healthcare databases and numerous trial regi …
SEARCH METHODS: We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialised Register, on 5 July 2018. ALOIS contain …
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN. Barnes H, et al. Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2. Cochrane Database Syst Rev. 2018. PMID: 29297205 Free PMC article. Review.
Similarly, it is not clear whether histological subtype, disease duration, or disease extent can be used to predict treatment responsiveness. ...SEARCH METHODS: We performed searches on CENTRAL, MEDLINE, Embase, CINAHL, and Web of Science up to May 2017. We handsear …
Similarly, it is not clear whether histological subtype, disease duration, or disease extent can be used to predict treatment …
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
Simpson TC, Weldon JC, Worthington HV, Needleman I, Wild SH, Moles DR, Stevenson B, Furness S, Iheozor-Ejiofor Z. Simpson TC, et al. Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD004714. doi: 10.1002/14651858.CD004714.pub3. Cochrane Database Syst Rev. 2015. PMID: 26545069 Free PMC article. Updated. Review.
SELECTION CRITERIA: We searched for randomised controlled trials (RCTs) of people with type 1 or type 2 DM (T1DM/T2DM) with a diagnosis of periodontitis. ...AUTHORS' CONCLUSIONS: There is low quality evidence that the treatment of periodontal disease by SRP does imp …
SELECTION CRITERIA: We searched for randomised controlled trials (RCTs) of people with type 1 or type 2 DM (T1DM/T2DM) with a diagnos …
Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial.
Troche MS, Curtis JA, Sevitz JS, Dakin AE, Perry SE, Borders JC, Grande AA, Mou Y, Vanegas-Arroyave N, Hegland KW. Troche MS, et al. Mov Disord. 2023 Feb;38(2):201-211. doi: 10.1002/mds.29268. Epub 2022 Nov 7. Mov Disord. 2023. PMID: 36345090 Clinical Trial.
METHODS: Participants with PD and dysphagia were recruited for this prospective phase II randomized-blinded controlled clinical trial. Participants completed baseline assessment, 5 weeks of EMST or smTAP, and a post-training assessment. ...Voluntary PEFR incr …
METHODS: Participants with PD and dysphagia were recruited for this prospective phase II randomized-blinded controlled clinical
Psychological therapies for the management of chronic and recurrent pain in children and adolescents.
Fisher E, Law E, Dudeney J, Palermo TM, Stewart G, Eccleston C. Fisher E, et al. Cochrane Database Syst Rev. 2018 Sep 29;9(9):CD003968. doi: 10.1002/14651858.CD003968.pub5. Cochrane Database Syst Rev. 2018. PMID: 30270423 Free PMC article. Review.
We assessed the impact of both conditions on four outcomes: pain, disability, depression, and anxiety. We extracted data at two time points; post-treatment (immediately or the earliest data available following end of treatment) and at follow-up (between three and 12 …
We assessed the impact of both conditions on four outcomes: pain, disability, depression, and anxiety. We extracted data at two time points; …
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
van Nieuwkoop C, van der Starre WE, Stalenhoef JE, van Aartrijk AM, van der Reijden TJ, Vollaard AM, Delfos NM, van 't Wout JW, Blom JW, Spelt IC, Leyten EM, Koster T, Ablij HC, van der Beek MT, Knol MJ, van Dissel JT. van Nieuwkoop C, et al. BMC Med. 2017 Apr 3;15(1):70. doi: 10.1186/s12916-017-0835-3. BMC Med. 2017. PMID: 28366170 Free PMC article. Clinical Trial.
Patients indicated to receive antimicrobial treatment for at least 14 days were excluded from randomization. The primary endpoint was the clinical cure rate through the 10- to 18-day post-treatment visit with preset subgroup analysis including sex. Sec …
Patients indicated to receive antimicrobial treatment for at least 14 days were excluded from randomization. The primary endpoint was …
Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
Hundemer GL. Hundemer GL. Curr Cardiol Rep. 2019 Jul 27;21(9):93. doi: 10.1007/s11886-019-1185-x. Curr Cardiol Rep. 2019. PMID: 31352525 Review.
Prior to targeted therapy, PA is associated with substantially higher rates of cardiovascular disease compared with essential hypertension. Surgical adrenalectomy is highly effective in curing or improving hypertension as well as mitigating cardiovascular disease ri …
Prior to targeted therapy, PA is associated with substantially higher rates of cardiovascular disease compared with essential hyperte …
1,498 results